Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06393036
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-04
First Post:
2024-04-24
Brief Title:
The Effect of OSA on Severity and Prognosis of Patients With IgAN
Sponsor:
Peking University First Hospital
Organization:
Peking University First Hospital
Study Overview
Official Title:
The Effect of Obstructive Sleep Apnea on Severity and Prognosis of Patients With IgA Nephropathy
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to investigate the influence of obstructive sleep apnea hypopnea syndrome OSA on the severity and prognosis of patients with IgA nephropathy IgAN and to evaluate the therapeutic effect of continuous positive airway pressure CPAP intervention in such patients Although the study is designed as an observational cohort study where patients self-selected whether to receive treatment rather than being assigned there is still an intervention project CPAP present in the observational cohort Through a cohort study design scientific evidences are expected for clinical decision-making and optimize treatment strategies for patients with OSA and IgAN
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None